Wan et al. corroborated these findings and further clarified that the PGC-1α protection against the development of hepatic steatosis and insulin resistance is by enhancing IL-10-mediated anti-inflammatory responses [163]. The gene discussed is PPARGC1A; the disease is fatty liver disease.